JP2007509982A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007509982A5 JP2007509982A5 JP2006538382A JP2006538382A JP2007509982A5 JP 2007509982 A5 JP2007509982 A5 JP 2007509982A5 JP 2006538382 A JP2006538382 A JP 2006538382A JP 2006538382 A JP2006538382 A JP 2006538382A JP 2007509982 A5 JP2007509982 A5 JP 2007509982A5
- Authority
- JP
- Japan
- Prior art keywords
- protease
- mammal
- composition
- administration
- cck
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091005804 Peptidases Proteins 0.000 claims 74
- 239000004365 Protease Substances 0.000 claims 70
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 69
- 235000019419 proteases Nutrition 0.000 claims 69
- 239000000203 mixture Substances 0.000 claims 57
- 102100025841 Cholecystokinin Human genes 0.000 claims 54
- 101800001982 Cholecystokinin Proteins 0.000 claims 54
- 241000124008 Mammalia Species 0.000 claims 54
- 229940107137 cholecystokinin Drugs 0.000 claims 54
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 claims 54
- 239000003431 cross linking reagent Substances 0.000 claims 12
- 235000013305 food Nutrition 0.000 claims 12
- 208000004998 Abdominal Pain Diseases 0.000 claims 11
- 239000003814 drug Substances 0.000 claims 8
- 238000004519 manufacturing process Methods 0.000 claims 8
- 239000003826 tablet Substances 0.000 claims 7
- 230000036470 plasma concentration Effects 0.000 claims 6
- 102000035195 Peptidases Human genes 0.000 claims 5
- 235000019833 protease Nutrition 0.000 claims 4
- 108010059712 Pronase Proteins 0.000 claims 2
- 101710180012 Protease 7 Proteins 0.000 claims 2
- 108010038346 Seaprose S Proteins 0.000 claims 2
- 208000022531 anorexia Diseases 0.000 claims 2
- 206010061428 decreased appetite Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 235000012054 meals Nutrition 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 239000004382 Amylase Substances 0.000 claims 1
- 102000013142 Amylases Human genes 0.000 claims 1
- 108010065511 Amylases Proteins 0.000 claims 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 claims 1
- 108090000145 Bacillolysin Proteins 0.000 claims 1
- 208000000668 Chronic Pancreatitis Diseases 0.000 claims 1
- 201000003883 Cystic fibrosis Diseases 0.000 claims 1
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- 102000004882 Lipase Human genes 0.000 claims 1
- 108090001060 Lipase Proteins 0.000 claims 1
- 239000004367 Lipase Substances 0.000 claims 1
- 102000035092 Neutral proteases Human genes 0.000 claims 1
- 108091005507 Neutral proteases Proteins 0.000 claims 1
- 206010033645 Pancreatitis Diseases 0.000 claims 1
- 206010033647 Pancreatitis acute Diseases 0.000 claims 1
- 206010033649 Pancreatitis chronic Diseases 0.000 claims 1
- 102000018540 Peptidase, metallopeptidases Human genes 0.000 claims 1
- 108050007685 Peptidase, metallopeptidases Proteins 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 1
- 239000004473 Threonine Substances 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 201000003229 acute pancreatitis Diseases 0.000 claims 1
- 150000001298 alcohols Chemical class 0.000 claims 1
- 108010051215 alkaline peptidase Proteins 0.000 claims 1
- 235000019418 amylase Nutrition 0.000 claims 1
- 150000008064 anhydrides Chemical class 0.000 claims 1
- 229940009098 aspartate Drugs 0.000 claims 1
- 239000007894 caplet Substances 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 235000014633 carbohydrates Nutrition 0.000 claims 1
- 125000005442 diisocyanate group Chemical group 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 239000006185 dispersion Substances 0.000 claims 1
- 239000008298 dragée Substances 0.000 claims 1
- 230000004064 dysfunction Effects 0.000 claims 1
- 239000002702 enteric coating Substances 0.000 claims 1
- 238000009505 enteric coating Methods 0.000 claims 1
- 238000011902 gastrointestinal surgery Methods 0.000 claims 1
- 150000004820 halides Chemical class 0.000 claims 1
- 150000005694 halopyrimidines Chemical class 0.000 claims 1
- POOYFSLWYLDQMD-UHFFFAOYSA-N heptacalcium;zinc Chemical compound [Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Zn+2] POOYFSLWYLDQMD-UHFFFAOYSA-N 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 235000019421 lipase Nutrition 0.000 claims 1
- 150000002632 lipids Chemical class 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 229920001308 poly(aminoacid) Polymers 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 230000002980 postoperative effect Effects 0.000 claims 1
- 108010042388 protease C Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229950000112 serrapeptase Drugs 0.000 claims 1
- 108010038132 serratiopeptidase Proteins 0.000 claims 1
- 239000002002 slurry Substances 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 150000003573 thiols Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51555203P | 2003-10-29 | 2003-10-29 | |
| US52749003P | 2003-12-05 | 2003-12-05 | |
| PCT/US2004/036228 WO2005042012A1 (en) | 2003-10-29 | 2004-10-29 | Non-pancreatic proteases for controlling plasma cholecystokinin (cck) concentration and for treating pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007509982A JP2007509982A (ja) | 2007-04-19 |
| JP2007509982A5 true JP2007509982A5 (cg-RX-API-DMAC10.html) | 2007-11-15 |
Family
ID=34556008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006538382A Pending JP2007509982A (ja) | 2003-10-29 | 2004-10-29 | 血漿コレシストキニン（ｃｃｋ）濃度を制御するための非膵臓プロテアーゼおよび痛みを処置するための非膵臓プロテアーゼ |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US7459155B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1682168B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2007509982A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20060127857A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2004285558A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2544156C (cg-RX-API-DMAC10.html) |
| ES (1) | ES2421538T3 (cg-RX-API-DMAC10.html) |
| IL (1) | IL175210A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2005042012A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1319655B1 (it) | 2000-11-15 | 2003-10-23 | Eurand Int | Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione. |
| DE102006008613A1 (de) * | 2006-02-24 | 2007-08-30 | Dade Behring Marburg Gmbh | Stabilisierte Zubereitungen von Serin-Endopeptidasen, deren Herstellung und Verwendung |
| US20090175842A1 (en) * | 2006-07-11 | 2009-07-09 | Chandrakant Laxminarayan Rathi | Dietary anti-bacterial compositions |
| PT2079445E (pt) | 2007-02-20 | 2016-02-29 | Allergan Pharmaceuticals Internat Ltd | Composições de enzimas digestivas estáveis |
| WO2009109856A2 (en) | 2008-03-07 | 2009-09-11 | Axcan Pharma Inc. | Method for detecting infectious parvovirus in pharmaceutical preparations |
| US8784884B2 (en) * | 2009-09-17 | 2014-07-22 | Stephen Perrett | Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency |
| WO2011126811A2 (en) | 2010-03-30 | 2011-10-13 | Pfenex Inc. | High level expression of recombinant toxin proteins |
| EA029101B1 (ru) | 2010-10-01 | 2018-02-28 | Апталис Фарма Лимитид | Составы с низкой дозой панкрелипазы и кишечнорастворимым покрытием |
| WO2012155027A1 (en) | 2011-05-12 | 2012-11-15 | Healthpoint, Ltd. | Wound debridement compositions containing seaprose and methods of wound treatment using same |
| CA2843556A1 (en) | 2011-08-08 | 2013-02-14 | Aptalis Pharma Ltd. | Method for dissolution testing of solid compositions containing digestive enzymes |
| US20130156884A1 (en) * | 2011-12-19 | 2013-06-20 | Triarco Industries | Protease enzymes for increased protein digestion rate and absorption and methods of using the same |
| US9962430B2 (en) | 2012-02-15 | 2018-05-08 | Chirhoclin, Inc. | Methods for treating pain associated with chronic pancreatitis |
| KR20150013280A (ko) * | 2012-05-11 | 2015-02-04 | 스미스 앤드 네퓨, 인크. | 박테리아 균막을 제거하기 위한 세아프로제의 용도 |
| US11406718B2 (en) | 2012-05-29 | 2022-08-09 | Chirhoclin, Inc. | Methods of detecting pancreobiliary ductal leaks |
| EP3639846B1 (en) | 2013-08-09 | 2022-09-28 | Allergan Pharmaceuticals International Limited | Digestive enzyme composition suitable for enteral administration |
| SG11201602012RA (en) | 2013-09-25 | 2016-04-28 | Pronutria Inc | Compositions and formulations for maintaining and increasing muscle mass, strength, and performance and methods of production and use thereof |
| EP3157568A1 (en) | 2014-06-19 | 2017-04-26 | Aptalis Pharma Limited | Methods for removing viral contaminants from pancreatic extracts |
| WO2018020435A1 (en) | 2016-07-27 | 2018-02-01 | Smith & Nephew, Inc. | Use of thermolysin to reduce or eliminate bacterial biofilms from surfaces |
| US11413300B2 (en) | 2017-01-30 | 2022-08-16 | Smith & Nephew, Inc. | Synergistic combination of thermolysin and an antibacterial agent to reduce or eliminate bacterial biofilms from surfaces |
| US11744878B2 (en) | 2020-08-19 | 2023-09-05 | Chirhoclin, Inc. | Methods for treatment of COVID-19 syndrome |
| EP4369942A1 (en) | 2021-07-12 | 2024-05-22 | Zidkiyahu Simenhaus | Protein containing bio-active compositions comprising cellulose microparticle carriers |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2129947A1 (en) | 1971-03-23 | 1972-11-03 | Amano Pharma Co Ltd | Anti-inflammatory protease prepn - from aspergillus |
| JPS5692217A (en) * | 1979-12-26 | 1981-07-25 | Kowa Co | Easily absorbable enzyme preparation |
| JPS5826822A (ja) * | 1981-08-10 | 1983-02-17 | Kaken Pharmaceut Co Ltd | 慢性腎炎治療剤 |
| JPS608225A (ja) * | 1983-06-29 | 1985-01-17 | Kowa Co | 腸管吸収医薬組成物 |
| JPS62215533A (ja) * | 1986-03-17 | 1987-09-22 | Shigemi Fujisaki | 膠原病又は関節リウマチの予防治療剤 |
| JPS61293927A (ja) * | 1986-06-18 | 1986-12-24 | Kaken Pharmaceut Co Ltd | 肝臓疾患予防治療剤 |
| JPH01132533A (ja) * | 1987-11-18 | 1989-05-25 | Toa Yakuhin Kogyo Kk | 動物用薬剤 |
| JPH01238538A (ja) * | 1988-03-18 | 1989-09-22 | Toa Yakuhin Kogyo Kk | 健胃消化剤 |
| JPH02292226A (ja) | 1989-05-08 | 1990-12-03 | Shigemi Fujisaki | 障害された神経細胞賦活予防治療剤 |
| US5514373A (en) * | 1992-05-22 | 1996-05-07 | Harris, Jr.; Roosevelt D. | Topical preparation |
| US5628981A (en) * | 1994-12-30 | 1997-05-13 | Nano Systems L.L.C. | Formulations of oral gastrointestinal diagnostic x-ray contrast agents and oral gastrointestinal therapeutic agents |
| WO1998036734A1 (en) | 1997-02-21 | 1998-08-27 | Beth Israel Deaconess Medical Center Inc. | A novel nutritional therapy which minimizes plasma cholecystokinin (cck) levels |
| JPH1149699A (ja) | 1997-08-01 | 1999-02-23 | Masao Igarashi | 女性慢性下腹疼痛症候群治療剤 |
| US6413512B1 (en) * | 1998-02-13 | 2002-07-02 | National Enzyme Company | Composition and method for treating disease by increasing activated α2 macroglobulin in the blood and extravascular tissue |
| US6638906B1 (en) * | 1999-12-13 | 2003-10-28 | Nobex Corporation | Amphiphilic polymers and polypeptide conjugates comprising same |
| US20010046493A1 (en) * | 2000-02-24 | 2001-11-29 | Alex Margolin | Lipase-containing composition and methods of use thereof |
| RU2299074C2 (ru) * | 2000-11-02 | 2007-05-20 | Цилиан Аг | Применение полученных из инфузорий ферментов в качестве способствующих пищеварению лекарственных средств |
| AR032392A1 (es) * | 2001-01-19 | 2003-11-05 | Solvay Pharm Gmbh | Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado. |
| US20030026794A1 (en) * | 2001-07-31 | 2003-02-06 | Howard Fein | Selective enzyme treatment of skin conditions |
| US6713096B2 (en) * | 2002-01-04 | 2004-03-30 | Melaleuca, Inc. | Dietary supplements and methods for treating pain and inflammation |
| US20040038874A1 (en) * | 2002-08-22 | 2004-02-26 | Osemwota Omoigui | Method of treatment of persistent pain |
-
2004
- 2004-10-29 ES ES04796860T patent/ES2421538T3/es not_active Expired - Lifetime
- 2004-10-29 CA CA2544156A patent/CA2544156C/en not_active Expired - Fee Related
- 2004-10-29 US US10/977,737 patent/US7459155B2/en not_active Expired - Fee Related
- 2004-10-29 JP JP2006538382A patent/JP2007509982A/ja active Pending
- 2004-10-29 AU AU2004285558A patent/AU2004285558A1/en not_active Abandoned
- 2004-10-29 KR KR1020067010531A patent/KR20060127857A/ko not_active Withdrawn
- 2004-10-29 EP EP04796860.7A patent/EP1682168B1/en not_active Expired - Lifetime
- 2004-10-29 WO PCT/US2004/036228 patent/WO2005042012A1/en not_active Ceased
-
2006
- 2006-04-26 IL IL175210A patent/IL175210A/en not_active IP Right Cessation
-
2008
- 2008-10-24 US US12/258,122 patent/US20090081184A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2544156A1 (en) | Non-pancreatic proteases for controlling plasma cholecystokinin (cck) concentration and for treating pain | |
| JP6379143B2 (ja) | エクセナチドの経口投与用の方法及び組成物 | |
| CN102091330B (zh) | 含有缬沙坦和nep抑制剂的药物组合物 | |
| EP1595538A3 (en) | Modified release tamsulosin tablets | |
| JP2003524421A5 (cg-RX-API-DMAC10.html) | ||
| JP2003530342A (ja) | ＡＴ１レセプターアンタゴニスト又はＡＣＥインヒビター又はＨＭＧ−Ｃｏ−Ａレダクターゼインヒビターからなる群から選ばれた少なくとも２つの化合物の組合せ | |
| MXPA04002627A (es) | Formulaciones farmaceuticas que protegen compuestos farmaceuticos de ambientes acidos. | |
| WO2004050037A2 (en) | Lactoferrin in the reduction of circulating cholesterol, vascular inflammation, atherosclerosis and cardiovascular disease | |
| JP2005528430A5 (cg-RX-API-DMAC10.html) | ||
| TW200416031A (en) | Therapeutic treatment | |
| JP7554807B2 (ja) | 消化障害の予防および／または処置用の医薬組成物およびそれを製造する方法、並びにそれを含む医薬製品 | |
| TW201536357A (zh) | 用於治療心血管疾病之口服調配物 | |
| JP2012111773A (ja) | 経口吸収改善用医薬組成物 | |
| US20040197321A1 (en) | Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients | |
| KR20240050369A (ko) | Pcsk9 활성과 관련된 상태를 치료하기 위한 화합물 | |
| CN118159281A (zh) | 治疗pcsk9活性相关病况的化合物 | |
| US20100021505A1 (en) | Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients | |
| CA3055118C (en) | Pharmaceutical composition comprising pancreatin and a lipase-containing coating | |
| Koumallos et al. | Therapeutic interventions to renin-angiotensin-aldosterone system, and vascular redox state | |
| CN102274160B (zh) | 用于治疗对抗高血压药的抗药性和相关病症的方法和制剂 | |
| RU2057538C1 (ru) | Препарат для лечения желудочно-кишечных энзимопатий | |
| CA2503754A1 (en) | Composition and method to prevent or reduce diarrhea and steatorrhea in hiv patients | |
| CN1842342A (zh) | 治疗需要抑制胃酸分泌的病状的组合物 | |
| CN101014369A (zh) | 利用cox—2选择性抑制剂和ltb4受体拮抗剂的组合用于治疗炎症和疼痛的组合物 | |
| HK1155375A (en) | Methods and compositions for oral administration of exenatide |